In the latest episode of Benzinga’s Cannabis Insider podcast, Bret Worley, CEO of MC Nutraceuticals, discussed the company's leading role in the global cannabinoid market. With a presence in 29 countries and over 750 clients worldwide, MC Nutraceuticals exemplifies the untapped potential of cannabis-derived products.
Key To Global Success: Quality, Distribution And Innovation
Under Worley's guidance, MC Nutraceuticals has emerged as the largest global supplier of cannabinoids, focusing on innovation, science and distribution to navigate the complex landscape of the cannabis industry. "We're the leader in the hemp-derived cannabinoid market," Worley said, highlighting the company's expansive client base and strategic distribution centers, including a significant presence in the Czech Republic for European operations.
MC Nutraceuticals' success is attributed to its commitment to pure cannabinoids, in-house testing facilities and a robust sales team that sets it apart from competitors. This level of service has cemented its leadership, particularly in Europe and Southeast Asia.
Unlocking Minor Cannabinoids’ Potential
Worley also shed light on the importance of minor cannabinoids such as CBN, CBG and THCV, emphasizing their therapeutic benefits and potential to revolutionize consumer products. With an impressive portfolio of 46 cannabinoids, MC Nutraceuticals is at the vanguard of creating formulations that meet diverse consumer needs, from enhancing sleep to alleviating pain.
Commitment To Quality And Education
Addressing safety and quality, Worley underscored the company's investment in top-tier chemists and rigorous third-party testing to ensure product excellence. Moreover, Worley is passionate about educating the market on cannabinoids’ benefits, aiming to narrow the knowledge gap for consumers worldwide.
Navigating Regulatory Landscapes
His involvement in regulatory advocacy highlights the challenges and successes encountered in harmonizing hemp regulations across the United States. His efforts with the American Healthy Alternatives Association aim to support small hemp businesses and foster a regulatory environment conducive to growth and innovation.
Moving With Agility Into The Future Of Cannabinoids
As the cannabis sector rapidly evolves, MC Nutraceuticals’ focus on agility, consumer education and scientific advancement positions it as a key player in shaping the future of the industry.
Watch the full interview on Benzinga Cannabis' YouTube channel:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.